STOCKWATCH
·
Pharmaceuticals
Quarterly Result12 Nov 2025, 06:55 pm

BDH Industries Ltd Reports Q2 and H1 Results for FY 2025-26 with 8.33% YoY Growth in Revenue

AI Summary

BDH Industries Ltd has announced its standalone unaudited financial results for the second quarter and half year ended on 30th September 2025. The company's revenue from operations stands at ₹ 1,895.92 lakhs for Q2 and ₹ 3,758.34 lakhs for H1, reflecting a year-over-year growth of 8.33%. The company's segments, Pharmaceuticals and Renewable Energy, contributed ₹ 1,875.27 lakhs and ₹ 189.95 lakhs to Q2 revenue, respectively. The profit for the period stands at ₹ 261.91 lakhs. The company's assets amounted to ₹ 8,892.96 lakhs as of 30th September 2025.

Key Highlights

  • BDH Industries Ltd reports Q2 and H1 results for FY 2025-26
  • Revenue from operations stands at ₹ 1,895.92 lakhs for Q2 and ₹ 3,758.34 lakhs for H1
  • Year-over-year growth in revenue stands at 8.33%
  • Segment revenue: Pharmaceuticals - ₹ 1,875.27 lakhs, Renewable Energy - ₹ 189.95 lakhs
  • Profit for the period stands at ₹ 261.91 lakhs
BDH
Pharmaceuticals
BDH INDUSTRIES LTD.

Price Impact